case pres Flashcards
measured bpe
what is this & discuss results
BPE is a screening tool NOT a diagnostic tool; helps give a guide for tx
pt had bpe of 3 in all sextants measured
‘walk’ the probe around all of the teeth using enough pressure that will blanch a finger nail ~ 15-20g
WHO 0.5mm diameter ball ended probe
bpe of 3
black band partially visible
probing depths of at least 4mm present (3.5-5.5)
calculus / overhangs / plaque / BoP
how do you carry out mpbs
ramfjords teeth
16 21 24
36 41 44
using a WHO probe (ball end 0.5mm diameter)
teeth used in this case was
18 21 24
36 41 44
used to monitor pt engagement
why OPT & PAs
pt initially came in to emergency clinic where PA of 35 36 37 was taken to assess 36
pt refused xla on emergency clinic of 36 due to dental anxiety
struggled with gag reflex when taking PA so decided at r/v that an opt supplemented with PAs of 11 and 21 (due superimposition of cervical spine) would be better for this patient
OPT v PA
would need at least 7 or more PAs to get a full mouth of PAs which is 4 microsv per radiograph whereas one OPT is 20 microsv
radiation doses according to international atomic energy agency
what regulations do we follow regarding radiation dosage
IRMER17 & IRR17 in UK
IRR17 - deals with occupational exposures & exposures of general public. annual dose limits are specified
IRMER17 - deals with medical exposure of patients. roles inc referrer / practitioner / operator / employer (dentist can be all of these)
what is ICRP and what do they say regarding radiographs
international commission on radiological protection
3 basic principles
1. justified - must do more good than harm
2. optimised - should use as little radiation as is practicable (ALARP)
3. limited - individual dose limits are used to ensure no one has unacceptable dose
periodontal diagnosis and why
generalised periodontitis stage 3 grade c currently unstable with risk factor of ex smoker
generalised - >30% bone loss
stage 3 - interproximal bone loss mid 1/3 of root
grade c - % bone loss divided by pt age which in this case is 60/54 which is >1 so rapid progression
currently unstable - pockets greater than or equal to 4mm & BoP
(NOTE - typo in poster; remember to say this)
risk factors - ex smoker (smoked 10 a day for 15 years so 7.5 pack years) & currently socially smokes cannabis
what is periodontal disease
Periodontal diseases (gingivitis and periodontitis) are a group of inflammatory conditions that affect the
hard and soft supporting tissues of the teeth and can lead to poor aesthetics, tooth loss, loss of function and reduced quality of life. A plaque biofilm is essential for development.
Damage from periodontal disease causes irreversible bone loss which manifests as clinical loss of attachment
why is smoking a risk factor for periodontal disease
smoking alters the balance present in the biofilm of the mouth triggering an immune attack
increased production of inflammatory mediating cytokines causes tissue breakdown
there is reduced gingival blood flow - signs & symptoms are suppressed
impaired white cell function causes impaired wound healing
what defines an engaging patient
improvement in OH; greater than or equal to 50% improvement in plaque & bleeding scores OR
plaque levels less than or equal to 20% & bleeding levels less than or equal to 30%
OR
pt has met targets outlined in their personal self care plan as determined by their health care practitioner
why re evaluate 3mths after BSP step 2
3 mths gives enough time for healing & decreased pocket depths for:
- oedema to reduce (causing gingival recession)
- increased clinical attachment due to formation of junctional epithelium
this increases tissue tone & causes resistance to probing
what constitutes periodontal health
<10% BoP
pocket depth less than or equal to 4mm
no BoP at 4mm sites
note - this can be adjusted to the patient i.e. pt may have PPD of 5-6mm in absence of BoP which may not represent active disease
what is stability and how do we measure it
stability is a reflection of the current level of disease activity
assessing stability relies on measuring extent of BoP and level of PPD across dentition
what are the different results we can see at the 3mth re evaluation mark
- stable - BoP <10% / PDD <4mm / no BoP at 4mm sites
- in remission - BoP >10% / PPD <4mm / no BoP at 4mm sites
- unstable - PPD >5mm / PPD >4mm & BoP
according to BSP what does a code 3 mean
initial perio therapy and r/v in 3mths with localised 6PPC in involved sextants
- if no pockets greater than or equal to 4mm & no radiographic evidence of bone loss due to periodontitis then continue with code 0/1/2 pathway
- if pockets > than or equal to 4mm remain and / or radiographic evidence of bone loss due to periodontitis then continue with code 4 pathway
what is bsp step 1
building foundations for optimal treatment outcomes
- explain disease, risk factors & tx alternatives, risks & benefits inc no tx
- explain importance of OHI, encourage & support behaviour change for OH improvement
- reduce risk factors inc removal of plaque retentive features, smoking cessation, diabetes control interventions
- provide tailored OH inc ID cleaning, tp & MW, PMPR inc supra and sub gingival scaling of clinical crown
what is bsp step 2
if pt engaging with step 1 then can progress to step 2
engagement assessed via MPBs
- reinforce OH / risk factor control / behaviour change
- subgingival instrumentation (hand or powered) either alone or in combination
what happens after 3mth evaluation according to bsp
if unstable go to step 3 which is re performing subgingival PMPR for moderate pockets of 4-5mm & considering alternative causes / referral for deep residual pocketing of >6mm
if stable go to step 4 which is maintenance; supportive perio care encouraged as well as regular targeted PMPR (time frame decided with what pt needs dictate)
what is sciatica
sciatic nerve which runs from lower back to feet is irritated or compressed
nerve starts in lower back and runs down back of each leg
usually clears up in 12wks but can recur; influenced by poor sleep, stress & emotional wellbeing
issues with dental tx with regards to time in chair & getting into chair
pt manages sciatica flare ups with tramadol what is this
opioid painkiller
used to tx moderate to severe pain (often prescribed if weaker painkillers no longer work and you have long term pain)
pt taking standard tablets that contain 50mg
taking as and when required
can have withdrawal effects (dose should be gradually reduced) - agitation / anxious / shaking / sweating
tramadol mechanism of action
centrally acting synthetic opioid analgesic & SNRI (serotonin / norepinephrine reuptake inhibitor) it:
1. is an agonist of the opioid receptor (release of nociceptive neurotransmitters i.e. GABA / substance P / noradrenaline / acetylcholine is inhibited as decreases intracellular cAMP which modulates the release of nociceptive neurotransmitters)
2. inhibits serotonin reuptake
these pathways are complementary & synergistic; improving ability to modulate the perception of & response to pain
+ enantiomer inhibits serotonin reuptake & - enantiomer inhibits norepinephrine reuptake enhancing inhibitory effects on pain transmission in spinal cord
-> closes voltage gated calcium channels & opens calcium dependent potassium channels resulting in hyperpolarisation & a reduction in neuronal excitability
side effects of tramadol
dry mouth !!!!
arrythmia
respiratory depression
confusion
withdrawal
caution when prescribing tramadol
opioids co prescribed with benzodiazepines & benzodiazepine drugs can produce additive CNS depressant effects thereby increasing risk of sedation, respiratory depression, come & death
risk factors for candida
long term corticosteroid use
immunosuppressive drugs
broad spectrum ABs
diabetes
nutrition
dialysis
smoking
denture wearing
anaemia
steroid inhaler use
pseudomembranous candidiasis
white pronounced plaques
wiped away easily to leave bleeding erythematous surface
other types of candida
erythematous - red & angry; either atrophic from HIV or denture stomatitis
hyperplastic - white patches, less pronounced & plaque like than pseudomembranous, can’t be wiped off, associated with candidal leukoplakia which can be pre malignant
angular cheilitis - seen at commissures & angles of mouth
systemic candida tx
azoles - i.e. fluconazole / miconazole gel. inhibit ergosterol synthesis (fungistatic). c.glabrata resistant. avoid in warfarin / statins.
polyenes - i.e. nystatin. binds directly to ergosterol on cell membranes causing pores to open & cell contents to be lost (fungicidal).
nystatin prescription sdcep
nystatin oral suspension
100,000 units / ml
send 30ml
1ml after food 4x daily for 7 days
why was pt given nystatin
pt request no tablets as doesn’t like taking tablets
issue with chronic candida
yeasts in candida can metabolise simple sugars to alcohol & CO2 gas
acetaldehyde produced from subsequent alcoholic breakdown is a carcinogen (cancer causing chemical)
virulence factors of candida
phospholipase - degrades lipids, aids host cell penetration
haemolysin - degrades RBCs, facilitates hyphal invasion
proteinase - degrades protein, aids adhesion to epithelial cells
alters target site to prevent azoles from binding
changing cell membrane composition to prevent insertion of polyene
pt doesn’t have any of usual risk factors for candida what has caused this
pt not seen dentist in 10yrs & only quit smoking 1yr prior
could have had candida for a long time and not realised
perio guidelines followed
SDCEP
BSP
S3 guidelines - S3 format is the highest level of guideline production considering both a systematic appraisal of published evidence & clinical experience